Use of levosimendan with heart-lung machine fails to improve outcomes
Monday, March 20, 2017 - 09:01
in Health & Medicine
When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not significantly reduce rates of death, heart attack, kidney dialysis or use of a mechanical assist device among patients at high risk for low cardiac output syndrome, according to a new study.